Schedule 13D ownership disclosure

Whitehawk Therapeutics, Inc.

Common stock, par value $0.0001 per share · CUSIP: 00032Q104

Event date: 2025-03-04

Filing-level shares
2,272,941
Percent of class
4.9%
  • Neil DesaiReported CIK 0001878692

    Shares: 2,272,941 · Class: 4.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-034969
Form type
SCHEDULE 13D/A
Filer
Whitehawk Therapeutics, Inc.
CIK
CIK 1422142
Filed
Mar 06, 2025
Reporting period
Mar 04, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub